Anti-amyloid drug shows signs of preventing Alzheimer’s dementia
A clinical trial among people destined to develop early-onset Alzheimer’s disease and led by WashU Medicine researchers shows eliminating amyloid from the brain may prevent cognitive symptoms.
A closer look at biomolecular ‘Silly Putty’
Researchers at Washington University have developed a method to peer into biomolecular condensates, which could lead to a better understanding of condensate functions and their impairment in cancers and neurodegeneration.
$4.5 million supports pathbreaking neuroimmunology research
WashU Medicine has received a three-year $4.5 million grant from the Carol and Gene Ludwig Family Foundation, with the ultimate goal of developing new treatments for Alzheimer’s disease.
Electrochemical field key to how dementia precursors ‘break bad’
Researchers at Washington University have found electrochemical rules for how toxic protein assemblies form, opening the way for better treatments of dementia.
Next-gen Alzheimer’s drugs extend independent living by months
An analysis by researchers at WashU Medicine interprets the benefits of new Alzheimer’s drugs in a way that aims to help patients and families make informed treatment decisions.
Patient defies genetic fate to avoid Alzheimer’s
A Washington man who inherited a mutation that should have caused him to develop Alzheimer’s decades ago remains mentally sharp. A new study of his case by researchers at WashU Medicine aims to identify potential routes to preventing or treating the disease.
International Alzheimer’s prevention trial in young adults begins
The first participants have been enrolled in an international clinical trial, led by WashU Medicine, aimed at preventing Alzheimer’s disease in young adults at high risk of the disease.
Grant will fund development of vaccines to prevent dementia
Researchers at Washington University are looking to find new ways to design vaccines to protect against inflammation in the brain that causes dementia.
New drug targets for Alzheimer’s identified from cerebrospinal fluid
Researchers at WashU Medicine have linked disease-related proteins and genes to identify specific cellular pathways responsible for Alzheimer’s genesis and progression.
Healthy brains suppress inappropriate immune responses
Researchers at WashU Medicine have found a process in which the brain guards against attack by the immune system, opening opportunities to pursue new therapies for diseases such as multiple sclerosis and Alzheimer’s.
Older Stories